STOCK TITAN
  1. Home
  2. Sec-filings
  3. CL
  4. [144] COLGATE PALMOLIVE CO SEC Filing

Colgate-Palmolive (NYSE: CL) officer to sell 10,000 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

COLGATE PALMOLIVE CO (CL) insider Panagiotis Tsourapas filed a notice of proposed sale of 10,000 shares of common stock of Colgate-Palmolive. The shares are to be sold through Merrill Lynch on the NYSE, with an aggregate market value listed as $920,477.17.

The filing also lists equity awards that will provide shares in the future, including 799 shares from vesting of restricted stock unit awards on 09/13/2024 and 9,201 shares from vesting of performance share unit awards on 02/23/2026, all granted under Colgate-Palmolive’s equity compensation plan.

Positive

  • None.

Negative

  • None.
Common stock shares to be sold 10,000 shares Shares of Colgate-Palmolive common stock covered by the Form 144 notice
Aggregate market value $920,477.17 Aggregate market value for 10,000 Colgate-Palmolive shares in the Form 144
CUSIP 797172829 CUSIP number associated with Colgate-Palmolive common stock in the filing
RSU vesting shares 799 shares Shares from vesting of restricted stock unit awards on 09/13/2024
PSU vesting shares 9,201 shares Shares from vesting of performance share unit awards on 02/23/2026
RSU vesting date 09/13/2024 Vesting date for 799 restricted stock unit award shares
PSU vesting date 02/23/2026 Vesting date for 9,201 performance share unit award shares
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
restricted stock unit awards financial
"Vesting of restricted stock unit awards | COLGATE PALMOLIVE CO"
Restricted stock unit awards are company promises to deliver a specific number of shares to employees or service providers in the future once conditions—such as staying with the company for a set time or meeting performance targets—are met. They matter to investors because when the promises convert into actual shares they increase the total share count and can reduce earnings per share, while also aligning recipients’ interests with stock performance much like deferred pay that turns into ownership if goals are met.
performance share unit awards financial
"Vesting of performance share unit awards | COLGATE PALMOLIVE CO"
equity compensation plan financial
"Granted as part of issuer equity compensation plan"
A plan by which a company gives employees, directors or contractors ownership or the right to buy ownership in the company through stock, options or similar awards — think of promising slices of the company pie as part of someone's pay. It matters to investors because these awards can change the number of shares outstanding, affect reported profits and influence management’s decisions; large or generous plans can dilute existing holders and alter incentives over time.

FAQ

What does Colgate-Palmolive (CL) insider Panagiotis Tsourapas plan to sell under this Form 144?
The notice covers a proposed sale of 10,000 shares of Colgate-Palmolive common stock, to be sold through Merrill Lynch on the NYSE, with an aggregate market value shown as $920,477.17 at the time of the filing.

Which equity awards for Colgate-Palmolive (CL) are referenced in this Form 144?
The filing lists restricted stock unit awards and performance share unit awards granted under Colgate-Palmolive’s equity compensation plan, with 799 shares vesting on 09/13/2024 and 9,201 shares vesting on 02/23/2026.

What is the aggregate market value of the Colgate-Palmolive (CL) shares covered by this Form 144?
The Form 144 states that the 10,000 shares of Colgate-Palmolive common stock proposed to be sold have an aggregate market value of $920,477.17 based on the information provided in the filing.

On which exchange are the Colgate-Palmolive (CL) shares in this Form 144 expected to be sold?
The Form 144 notes that the 10,000 shares of Colgate-Palmolive common stock are to be sold on the NYSE, with Merrill Lynch listed as the broker for the transaction.

Who is the reporting person in this Colgate-Palmolive (CL) Form 144 filing?
The Form 144 identifies Panagiotis Tsourapas as the person for whose account the Colgate-Palmolive common stock is to be sold, and indicates that this person is an officer of the issuer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR